Jan J. Schuringa

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.

Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.

Journal: European journal of pharmacology
Published: February 21, 2026

Glutathionylated leaky mitochondrial pores as target in AML.

Glutathionylated leaky mitochondrial pores as target in AML.

Journal: Blood
Published: February 19, 2026

Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches.

Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches.

Journal: Journal of thrombosis and haemostasis : JTH
Published: January 20, 2026

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia.

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia.

Journal: Blood neoplasia
Published: December 02, 2025

Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.

Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.

Journal: Cell death discovery
Published: October 14, 2025

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Journal: Haematologica
Published: September 08, 2025

Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiation.

Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiation.

Journal: Nucleic acids research
Published: July 09, 2025

Validation of a Multiplex mRNA- and gDNA-Based Droplet Digital PCR Assay in Acute Myeloid Leukemia Patients with an NPM1 Mutation.

Validation of a Multiplex mRNA- and gDNA-Based Droplet Digital PCR Assay in Acute Myeloid Leukemia Patients with an NPM1 Mutation.

Journal: Clinical chemistry
Published: May 19, 2025

Corrigendum to "Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes" [Atherosclerosis (2024) 395 117609].

Corrigendum to "Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes" [Atherosclerosis (2024) 395 117609].

Journal: Atherosclerosis
Published: April 18, 2025

High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosis.

High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosis.

Journal: Immunologic research
Published: April 10, 2025

Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival.

Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival.

Journal: bioRxiv : the preprint server for biology
Published: March 17, 2025

Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets.

Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets.

Journal: British journal of haematology
Published: March 11, 2025
Showing 1-12 of 105

Last Updated: 09/26/2026